Chemours (NYSE:CC) Stock Sees Heavy Call Option Buying

The Chemours Company (NYSE:CC) saw unusually large options trading on Wednesday. Stock investors purchased 21,465 call options on the company. This represents an increase of approximately 633% compared to the typical volume of 2,930 call options.

Key Chemours News

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Stronger titanium dioxide pricing and growth in Advanced Performance Materials (APM) partly offset weak Thermal & Specialized Solutions (TSS) volumes in the third quarter. Zacks Q3 earnings report
• Negative Sentiment: Multiple law firms publicized a securities class action filed against Chemours and certain officers. The suit covers investors who acquired shares from February 20 through August 4, 2026, and alleges that the company misrepresented or failed to disclose weakening Opteon aftermarket demand while reaffirming its 2026 outlook. These are allegations, not established findings; the lead-plaintiff deadline is December 7. The litigation adds legal and reputational risk. Pomerantz class action announcement
• Negative Sentiment: Chemours’ third-quarter EPS of $0.21 fell short of the $0.26 analyst consensus, with weak TSS volumes weighing on results, despite revenue slightly exceeding expectations. Zacks Q3 earnings report
• Negative Sentiment: JPMorgan lowered its price target from $15 to $14 and maintained a Neutral rating, signaling more limited expected upside. JPMorgan rating information

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CC shares. Mizuho downgraded Chemours from an “outperform” rating to a “neutral” rating and dropped their target price for the stock from $18.00 to $15.00 in a report on Wednesday, October 14th. Truist Financial reduced their target price on Chemours from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Wednesday, November 4th. Barclays started coverage on shares of Chemours in a report on Monday, October 12th. They set an “equal weight” rating and a $16.00 price target on the stock. Morgan Stanley set a $18.00 target price on Chemours in a report on Monday, August 10th. Finally, Royal Bank Of Canada downgraded shares of Chemours from an “outperform” rating to a “sector perform” rating and set a $14.00 price target for the company. in a research note on Tuesday, October 13th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Chemours currently has a consensus rating of “Hold” and an average price target of $17.36.

Chemours Stock Up 1.4%

Shares of Chemours stock opened at $13.46 on Wednesday. Chemours has a one year low of $10.44 and a one year high of $28.67. The company has a debt-to-equity ratio of 24.25, a current ratio of 1.81 and a quick ratio of 0.98. The stock’s 50-day moving average is $13.87 and its 200 day moving average is $18.19. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of -13.20 and a beta of 1.47.

Chemours (NYSE:CC) last issued its earnings results on Monday, November 2nd. The specialty chemicals company reported $0.21 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.05). The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.53 billion. Chemours had a positive return on equity of 76.52% and a negative net margin of 2.64%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.40 earnings per share. Equities research analysts anticipate that Chemours will post 0.82 EPS for the current year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, November 16th will be issued a dividend of $0.0875 per share. The ex-dividend date is Monday, November 16th. This represents a $0.35 annualized dividend and a dividend yield of 2.6%. Chemours’s dividend payout ratio is currently -34.31%.

Institutional Trading of Chemours

Several large investors have recently made changes to their positions in the company. Public Sector Pension Investment Board grew its stake in Chemours by 1.6% in the third quarter. Public Sector Pension Investment Board now owns 524,974 shares of the specialty chemicals company’s stock valued at $6,851,000 after acquiring an additional 8,311 shares during the period. Maryland State Retirement & Pension System raised its position in shares of Chemours by 53.7% during the third quarter. Maryland State Retirement & Pension System now owns 33,631 shares of the specialty chemicals company’s stock worth $456,000 after purchasing an additional 11,752 shares during the period. Jefferies Financial Group Inc. raised its position in shares of Chemours by 251.8% during the third quarter. Jefferies Financial Group Inc. now owns 2,742,068 shares of the specialty chemicals company’s stock worth $37,210,000 after purchasing an additional 1,962,523 shares during the period. Parallel Advisors LLC lifted its holdings in shares of Chemours by 15.1% in the 3rd quarter. Parallel Advisors LLC now owns 5,926 shares of the specialty chemicals company’s stock worth $80,000 after purchasing an additional 776 shares in the last quarter. Finally, Pekin Hardy Strauss Inc. lifted its holdings in shares of Chemours by 150.6% in the 3rd quarter. Pekin Hardy Strauss Inc. now owns 201,082 shares of the specialty chemicals company’s stock worth $2,729,000 after purchasing an additional 120,832 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Company Profile

The Chemours Company is a global chemicals manufacturer spun off from DuPont in 2015 and headquartered in Wilmington, Delaware. It develops and produces materials used in industries ranging from construction and transportation to electronics and energy. Chemours’ Titanium Technologies business makes titanium dioxide (TiO?) pigment, sold under the Ti-Pure brand, which is used to add whiteness, brightness and opacity to products such as paints, coatings, plastics and paper. Its Thermal & Specialized Solutions business supplies refrigerants, foam-blowing agents and other specialty fluids, including products marketed under the Opteon and Freon brands.